New treatment option for Chronic Low Back Pain
Official title VRFR- Immersive Virtual Reality Use in a Spine Functional Restoration Program - A Feasibility Study
ClinicalTrials.gov ID: NCT06724679
What this study is testing
- What it's testing
- This clinical trial investigates the feasibility of integrating immersive virtual reality (VR) technology into a functional restoration program (FRP) for patients with chronic low back pain (CLBP). The study aims to assess the acceptability, usability, and impact of a VR headset on both healthcare providers and patients participating in a group-based rehabilitation program.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Caregiver Caregivers involved in RFR programs at participating centers and likely to use the VR tool during the program. Consent of the caregiver to...
- Aged between 18 and 65 years.
- Diagnosed with chronic low back pain lasting more than three months, with secondary causes excluded.
- Candidates for integration into an RFR program at one of the participating centers.
- Affiliated with or beneficiaries of a social security scheme.
You likely can't join if
- Presence of any other condition incompatible with the RFR program.
- Recent surgery or trauma (within the last month).
- Contraindications for using the VR device, including unstable epilepsy, facial trauma within the last three months, hearing or visual impairments, or...
- Visual impairments preventing the use of the VR device.
- Pregnancy or breastfeeding.
- Poor comprehension of the French language.
See the full eligibility criteria
- Caregiver Caregivers involved in RFR programs at participating centers and likely to use the VR tool during the program. Consent of the caregiver to participate in the study. Patient
- Aged between 18 and 65 years.
- Diagnosed with chronic low back pain lasting more than three months, with secondary causes excluded.
- Candidates for integration into an RFR program at one of the participating centers.
- Affiliated with or beneficiaries of a social security scheme.
- Provide informed consent to participate in the study Patient
- Presence of any other condition incompatible with the RFR program.
- Recent surgery or trauma (within the last month).
- Contraindications for using the VR device, including unstable epilepsy, facial trauma within the last three months, hearing or visual impairments, or previous experiences of pain, dizziness, or nausea triggered by VR...
- Visual impairments preventing the use of the VR device.
- Pregnancy or breastfeeding.
- Poor comprehension of the French language.
- Incarceration by judicial or administrative decision.
- Undergoing compulsory psychiatric treatment.
- Subject to legal protection measures.
- Incapable of providing informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Cholet, France
- Laval, France
- Rennes, France
- Vannes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Cholet, France; Laval, France; Rennes, France; Vannes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.